Hepatocyte growth factor has been shown to interact with C-Met.

The hepatocyte growth factor receptor protein possesses tyrosine-kinase activity.

This phenotype mimics an effect produced by hepatocyte growth factor which may participate in various aspects of cancer, including metastasis.

Kringle domains have been found in plasminogen, hepatocyte growth factors, prothrombin, and apolipoprotein(a).

Stromal cell secretion of hepatocyte growth factor (HGF).

Epinephrine induces platelet aggregation, and so does hepatocyte growth factor (HGF).

RPE cells express the receptor for hepatocyte growth factor (HGF).

Hepatocyte growth factor (HGF)

Hepatocyte growth factor is secreted by mesenchymal cells and acts as a multi-functional cytokine on cells of mainly epithelial origin.

Hepatocyte growth factor (HGF) is the only known ligand of the MET receptor.

It is designed to express isoforms of hepatocyte growth factor (HGF) for the formation of new blood vessels when injected around ischemic tissue.

Hepatocyte growth factor activator is a protein that in humans is encoded by the HGFAC gene.

Hepatocyte growth factor has also been shown to upregulate the synthesis of SP-A in rat type II cells [ 25 ] .

PTPmu has also been shown to interact with the c-Met hepatocyte growth factor receptor, a protein that is also localized to adherens junctions.

This cytokine and the hepatocyte growth factor (HGF) form a heterodimer that functions as a pre-pro-B cell growth-stimulating factor.

Met tyrosine kinase is the receptor for hepatocyte growth factor (HGF a.k.a. scatter factor, SF).

Vasodilation (distended blood vessels), secretion of growth factors (such as platelet-derived growth factor and hepatocyte growth factor) from the lungs, and other mechanisms have been proposed.

Fetuins have been implicated in several diverse functions, including osteogenesis and bone resorption, regulation of the insulin and hepatocyte growth factor receptors, and response to systemic inflammation.

Approximately 20% of drug resistance is caused by amplification of the hepatocyte growth factor receptor, which drives ERBB3 dependent activation of PI3K.

Hepatocyte growth factor regulates cell growth, cell motility, and morphogenesis by activating a tyrosine kinase signaling cascade after binding to the proto-oncogenic c-Met receptor.

Uptake is stimulated by the binding of listerial internalins (Inl) to E-cadherin, a host cell adhesion factor, or Met (c-Met), hepatocyte growth factor.

By analogy, a splicing variant of the hepatocyte growth factor (HGF) gene produces a truncated protein, which is a natural antagonist of HGF.

Chess and coworkers have shown that transforming growth factor-α and hepatocyte growth factor increase the phosphorylation of p44/p42 MAPK in H441 cells [ 23 ] .

Hepatocyte growth factor (HGF), an angiogenesis promoting growth factor, is activated by HGF activation factor, a serine protease related to plasminogen.

Nemosis of fibroblasts, or mesenchymal cells in general, generates large amounts of mediators of inflammation, such as prostaglandins, as well as growth factors such as hepatocyte growth factor.